Skip to content

Clinical trials

Observational Lung Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Observational Clear all

427 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200113
200211
20034
20049
20058
200610
20074
20097
20102
201110
20127
201313
201410
20156
201614
201720
201813
201920
202025
202122
202219
202325
202423
202512
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed283
Unknown status52
Recruiting34
Terminated19
Active, not recruiting16
Enrolling by invitation10
Withdrawn7
Not yet recruiting5
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)90
AstraZeneca10
Weill Medical College of Cornell University8
University of Pittsburgh7
University of New Mexico6
Brigham and Women's Hospital5
National Institute of Environmental Health Sciences (NIEHS)5
Columbia University4
NYU Langone Health4
University of North Carolina, Chapel Hill4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases427
Asthma77
Pulmonary Disease, Chronic Obstructive61
Lung Neoplasms35
Cardiovascular Diseases34
Heart Diseases33
Sleep Apnea Syndromes23
Neoplasms21
Respiratory Tract Diseases20
Cystic Fibrosis18

Trials

Showing 76 to 100 of 427. Each trial links to its page on Pharma Observatory.

327 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.